Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)

NCT03992417 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

955

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatitis Atopic

Interventions

DRUG: Dupilumab SAR231893 (REGN668)

Sponsor

Sanofi

Collaborators

[object Object]